Literature DB >> 1705292

Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential.

R K Iles1, T Chard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1705292     DOI： 10.1016/s0022-5347(17)38367-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  10 in total

1.  beta hCG as a prognostic marker in adenocarcinoma of the prostate.

Authors:  M T Sheaff; J E Martin; D F Badenoch; S I Baithun
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

2.  Human chorionic gonadotropin in serum and neoplastic tissue from patients with bladder carcinoma.

Authors:  S Baltaci; S Küpeli; S D Sak; E Erden; K Sarica
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 3.  Bladder tumor markers: need, nature and application. 2. Tumor and tumor-associated antigens.

Authors:  M M Kirollos; S McDermott; R A Bradbrook
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

4.  Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.

Authors:  Michael Koslowski; Ozlem Türeci; Stefan Biesterfeld; Gerhard Seitz; Christoph Huber; Ugur Sahin
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

5.  Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.

Authors:  Z F Dobrowolski; B Byrska; M Dolezal
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

6.  Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation.

Authors:  M Tachibana; A Miyakawa; J Nakashima; M Murai; K Nakamura; A Kubo; J I Hata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.

Authors:  J Mora; N Gascón; J M Tabernero; J Rodríguez-Espinosa; F González-Sastre
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

8.  Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

Authors:  S D Fosså; A A Berner; A B Jacobsen; H Waehre; B Kvarstein; T Urnes; P Ogreid; T E Johansen; J Silde; J M Nesland
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

Review 9.  Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature.

Authors:  Anup Kasi Loknath Kumar; Megha Teeka Satyan; Jeffrey Holzbeierlein; Moben Mirza; Peter Van Veldhuizen
Journal:  J Med Case Rep       Date:  2014-05-13

10.  Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.

Authors:  M Kinugasa; R Nishimura; T Koizumi; K Morisue; T Higashida; T Natazuka; T Nakagawa; T Isobe; S Baba; K Hasegawa
Journal:  Jpn J Cancer Res       Date:  1995-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.